Impact of COVID-19 pandemic on the availability of maternal and child health products and childhood vaccines

ConclusionThis study illustrates that the availability of key essential medicines for maternal and child health in the study area was low. The overall stock-out situation of MCH products has worsened during COVID-19 compared to pre-COVID-19 pandemic. None of the surveyed MCH products met the ideal availability benchmark of 80% in the public hospitals. To allow governments to guarantee these products are constantly available and affordable, a variety of policy frameworks and choices addressing inevitable epidemics should exist.
Source: Journal of Pharmaceutical Policy and Practice - Category: Pharmaceuticals Source Type: research